Clinical Trial Update: A Study of the Ulthera® System for the Treatment of Axillary Hyperhidrosis [NA]

View source ↗

Summary

The clinical trial evaluating the Ulthera System for primary axillary hyperhidrosis (NCT01722461) has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperhidrosis

Drugs mentioned

• Ulthera System

Snippet

Sponsor: Ulthera, Inc | Conditions: Primary Axillary Hyperhidrosis | NA | Status: TERMINATED